cbdMD, Inc. (YCBD)
| Previous Close | 0.5199 |
| Open | 0.4800 |
| Bid | 0.5001 x 1000 |
| Ask | 0.5200 x 2200 |
| Day's Range | 0.4800 - 0.5299 |
| 52 Week Range | 0.4300 - 1.7300 |
| Volume | |
| Avg. Volume | 62,525 |
| Market Cap | 1.945M |
| Beta (5Y Monthly) | 2.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.9000 |
| Earnings Date | Dec 20, 2024 - Dec 24, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NewsfilecbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American
Charlotte, North Carolina--(Newsfile Corp. - August 26, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs, today announced that it received notice from the NYSE American LLC that it had accepted the Company's plan to regain compliance with the NYSE American ...
NewsfilecbdMD Delivers on Sequential Revenue Growth and Positive Net Income for Q3 2024
cbdMD Achieves Significant Reduction in Operating Loss as Operational Efficiencies Significantly Improve in Q3 2024 Charlotte, North Carolina--(Newsfile Corp. - August 14, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for our third quarter of fis
